Directory
>
Douglas Girgenti
Douglas Girgenti
Genetics and Oncogene Research | Melinta Therapeutics
New York, Town of Yorktown, United States
Douglas Girgenti
Summary
Douglas Girgenti is a seasoned medical professional with extensive experience in drug development and clinical research. As the Vice President of Drug Development at Melinta Therapeutics, he leads innovative projects in the pharmaceutical industry, focusing on vaccines and rare diseases. With a background in both pediatrics and adult medicine, Douglas has a unique perspective on patient care and clinical efficacy. His previous roles at renowned companies such as Pfizer and Boehringer Ingelheim highlight his expertise in immunology and clinical program leadership. A graduate of Stony Brook University with an M.D., he also holds dual bachelor's degrees in Genetics and Microbiology from Cornell University. Fluent in Spanish, he is well-equipped to engage with diverse populations in healthcare settings. Douglas is passionate about advancing medical research and improving patient outcomes through innovative therapies.
Douglas Girgenti
Work Experience
Vice President of Drug Development at
Melinta Therapeutics
October 2021 - Present
Douglas Girgenti
Education
Cornell University, Bachelor's Degree, Genetics, Microbiology
January 1986 - January 1989
Stony Brook University, Doctor of Medicine (M.D.)
January 1990 - January 1994
Cornell University, Bachelor of Science - BS, Microbiology/Genetics
January 1986 - January 1989
Frequently Asked Questions about Douglas Girgenti
What is Douglas Girgenti email address?
Douglas Girgenti's primary email address is ****************@boehringer-ingelheim.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Douglas Girgenti work for?
Douglas Girgenti is a Genetics and Oncogene Research at Melinta Therapeutics.
Where Douglas Girgenti graduated from?
Douglas Girgenti holds a degree in null from Cornell University.
How can I directly contact Douglas Girgenti?
To contact Douglas Girgenti directly, you can use the email address ****************@boehringer-ingelheim.com. Complete contact information is available upon registration with Muraena.
Who is Douglas Girgenti?
Douglas Girgenti is a seasoned medical professional with extensive experience in drug development and clinical research. As the Vice President of Drug Development at Melinta Therapeutics, he leads innovative projects in the pharmaceutical industry, focusing on vaccines and rare diseases. With a background in both pediatrics and adult medicine, Douglas has a unique perspective on patient care and clinical efficacy. His previous roles at renowned companies such as Pfizer and Boehringer Ingelheim highlight his expertise in immunology and clinical program leadership. A graduate of Stony Brook University with an M.D., he also holds dual bachelor's degrees in Genetics and Microbiology from Cornell University. Fluent in Spanish, he is well-equipped to engage with diverse populations in healthcare settings. Douglas is passionate about advancing medical research and improving patient outcomes through innovative therapies.
Douglas`s contact details
****************@boehringer-ingelheim.com
*********@melinta.com
Colleagues
VP Medical Affairs
Sr. Clinical Research Associate (Clinical Pharmacology)
Chemical Engineer
Product Manager, Kytril
Sales Representative
Oncology Sales Training Manager / Sales Manager / Region Trainer / Sales Representative
Benefits Manager